Immune response
Gene:
C21orf99 (official gene symbol)Other symbol:
C21orf99CT family:
CT85CT identifier:
CT85Aliases from NCBI:
CTSP1Humoral immune response
Spontaneous humoral immune responses against CTSP-1 have been detected in cancer patients.
| Tumor type | Tumor stage | Frequency | Antibody detection methodology | PMID |
|---|---|---|---|---|
| Prostate carcinoma | 37/147 (25%) | Western blot | 18214856 | |
| Breast carcinoma | 3/18 (17%) | Western blot | 17114284 | |
| Lung carcinoma | 1/13 (8%) | Western blot | 17114284 | |
| Melanoma | 1/22 (5%) | Western blot | 17114284 | |
| Prostate carcinoma | 5/24 (21%) | Western blot | 17114284 | |
| Gastrict carcinoma | 1/8 (12%) | Western blot | 17114284 | |
| Thyroid cancer | 2/10 (20%) | Western blot | 17114284 | |
| Uterine carcinoma | 1/22 (5%) | Western blot | 17114284 |
Cellular immune response
There are no published reports of spontaneous cellular immune responses against CT21orf99 in cancer patients.
Induced immune response
There are no published reports that evaluated induced immune responses in patients vaccinated with CT21orf99.